This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GSK-1325756

GlaxoSmithKline plc

Drug Names(s): GSK1325756, danirixin

Description: GSK-1325756 (1325756) is a immediate-release formulation chemokine receptor (CXCR2) antagonist.


GSK-1325756 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug